Renal Cancer - Results from #7100

Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials - Abstract February 28, 2014

Accuracy and implications of percutaneous renal biopsy in the management of renal masses - Abstract February 28, 2014

A randomized multicenter phase II trial on the efficacy of a hydrocolloid dressing containing ceramide with a low-friction external surface for hand-foot skin reaction caused by sorafenib in patients with renal cell carcinoma - Abstract February 28, 2014

MDCT imaging following nephrectomy for renal cell carcinoma: Protocol optimization and patterns of tumor recurrence - Abstract February 28, 2014

Renal cell carcinoma metastasis to the cerebellopontine cistern: Intraoperative Onyx embolization via direct needle puncture - Abstract February 28, 2014

Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic renal cell carcinoma - Abstract February 27, 2014

Dual-energy CT in assessing therapeutic response to radiofrequency ablation of renal cell carcinomas - Abstract February 27, 2014

Multimodality imaging of thyroid-like follicular renal cell carcinoma with lung metastases, a new emerging tumor entity - Abstract February 27, 2014

Histopathologic findings of small renal tumor biopsies performed immediately after cryoablation therapy: A retrospective study of 50 cases - Abstract February 26, 2014

Perioperative complications of robot-assisted partial nephrectomy - Abstract February 26, 2014

Assessing the response to targeted therapies in renal cell carcinoma: Technical insights and practical considerations - Abstract February 26, 2014

Using cumulative toxicity to identify the optimal second-line targeted therapy in patients with metastatic renal cell carcinoma: What's new? - Abstract February 25, 2014

Recommendations for the clinical and radiological evaluation of response to treatment in metastatic renal cell cancer - Abstract February 25, 2014

Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: Suggestions from bench to bedside - Abstract February 25, 2014

Compared with radical nephrectomy, nephron-sparing surgery offers a long-term survival advantage in patients between the ages of 20 and 44 years with renal cell carcinomas (≤ 4cm): An analysis of the SEER database - Abstract February 25, 2014

Molecular marker for predicting treatment response in advanced renal cell carcinoma: Does the promise fulfill clinical need? - Abstract February 21, 2014

T1a as the sole selection criterion for RFA of renal masses: Randomized controlled trials versus surgery should not be postponed - Abstract February 21, 2014

Laparoscopic treatment of renal cancer in children: A multicentric study and review of oncologic and surgical complications - Abstract February 21, 2014

Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with renal insufficiency - Abstract February 21, 2014

Small renal masses initially managed using active surveillance: Results from a retrospective study with long-term follow-up - Abstract February 21, 2014

Page 356 of 456